Temporal trends in bleeding events in acutemyocardial infarction : Insights from the SWEDEHEARTregistry
(2020) In European Heart Journal 41(7). p.833-843- Abstract
Aims To describe the time trends of in-hospital and out-of-hospital bleeding parallel to the development of new treatments and ischaemic outcomes over the last 20 years in a nationwide myocardial infarction (MI) population. Methods and results Patients with acute MI (n = 371 431) enrolled in the SWEDEHEART registry from 1995 until May 2018 were selected and evaluated for in-hospital bleeding and out-of-hospital bleeding events at 1 year. In-hospital bleeding increased from 0.5% to a peak at 2% 2005/2006 and thereafter slightly decreased to a new plateau around 1.3% by the end of the study period. Out-of-hospital bleeding increased in a stepwise fashion from 2.5% to 3.5 % in the middle of the study period and to 4.8% at the end of the... (More)
Aims To describe the time trends of in-hospital and out-of-hospital bleeding parallel to the development of new treatments and ischaemic outcomes over the last 20 years in a nationwide myocardial infarction (MI) population. Methods and results Patients with acute MI (n = 371 431) enrolled in the SWEDEHEART registry from 1995 until May 2018 were selected and evaluated for in-hospital bleeding and out-of-hospital bleeding events at 1 year. In-hospital bleeding increased from 0.5% to a peak at 2% 2005/2006 and thereafter slightly decreased to a new plateau around 1.3% by the end of the study period. Out-of-hospital bleeding increased in a stepwise fashion from 2.5% to 3.5 % in the middle of the study period and to 4.8% at the end of the study period. The increase in both in-hospital and out-ofhospital bleeding was parallel to increasing use of invasive strategy and adjunctive antithrombotic treatment, dual antiplatelet therapy (DAPT), and potent DAPT, while the decrease in in-hospital bleeding from 2007 to 2010 was parallel to implementation of bleeding avoidance strategies. In-hospital re-infarction decreased from 2.8% to 0.6% and out-of-hospital MI decreased from 12.6% to 7.1%. The composite out-of-hospital MI, cardiovascular death, and stroke decreased in a similar fashion from 18.4% to 9.1%. Conclusion During the last 20 years, the introduction of invasive and more intense antithrombotic treatment has been associated with an increase in bleeding events but concomitant there has been a substantial greater reduction of ischaemic events including improved survival.
(Less)
- author
- organization
- publishing date
- 2020
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Acute myocardial infarction, Bleeding, Registry, Temporal trends
- in
- European Heart Journal
- volume
- 41
- issue
- 7
- pages
- 11 pages
- publisher
- Oxford University Press
- external identifiers
-
- scopus:85079356955
- pmid:31504404
- ISSN
- 0195-668X
- DOI
- 10.1093/eurheartj/ehz593
- language
- English
- LU publication?
- yes
- id
- 77966d44-0011-404c-9977-e792ed5f8e6f
- date added to LUP
- 2020-12-18 12:35:01
- date last changed
- 2024-12-13 22:55:37
@article{77966d44-0011-404c-9977-e792ed5f8e6f, abstract = {{<p>Aims To describe the time trends of in-hospital and out-of-hospital bleeding parallel to the development of new treatments and ischaemic outcomes over the last 20 years in a nationwide myocardial infarction (MI) population. Methods and results Patients with acute MI (n = 371 431) enrolled in the SWEDEHEART registry from 1995 until May 2018 were selected and evaluated for in-hospital bleeding and out-of-hospital bleeding events at 1 year. In-hospital bleeding increased from 0.5% to a peak at 2% 2005/2006 and thereafter slightly decreased to a new plateau around 1.3% by the end of the study period. Out-of-hospital bleeding increased in a stepwise fashion from 2.5% to 3.5 % in the middle of the study period and to 4.8% at the end of the study period. The increase in both in-hospital and out-ofhospital bleeding was parallel to increasing use of invasive strategy and adjunctive antithrombotic treatment, dual antiplatelet therapy (DAPT), and potent DAPT, while the decrease in in-hospital bleeding from 2007 to 2010 was parallel to implementation of bleeding avoidance strategies. In-hospital re-infarction decreased from 2.8% to 0.6% and out-of-hospital MI decreased from 12.6% to 7.1%. The composite out-of-hospital MI, cardiovascular death, and stroke decreased in a similar fashion from 18.4% to 9.1%. Conclusion During the last 20 years, the introduction of invasive and more intense antithrombotic treatment has been associated with an increase in bleeding events but concomitant there has been a substantial greater reduction of ischaemic events including improved survival.</p>}}, author = {{Simonsson, Moa and LarsWallentin, L. and Alfredsson, Joakim and Erlinge, David and Angerud, Karin Hellstrom and Hofmann, Robin and Kellerth, Thomas and Lindhagen, Lars and Ravn-Fischer, Annica and Szummer, Karolina and Ueda, Peter and Yndigegn, Troels and Jernberg, Tomas}}, issn = {{0195-668X}}, keywords = {{Acute myocardial infarction; Bleeding; Registry; Temporal trends}}, language = {{eng}}, number = {{7}}, pages = {{833--843}}, publisher = {{Oxford University Press}}, series = {{European Heart Journal}}, title = {{Temporal trends in bleeding events in acutemyocardial infarction : Insights from the SWEDEHEARTregistry}}, url = {{http://dx.doi.org/10.1093/eurheartj/ehz593}}, doi = {{10.1093/eurheartj/ehz593}}, volume = {{41}}, year = {{2020}}, }